Myriad Genetics Adds 15 Clinically Actionable Genes to MyRisk® Hereditary Cancer Test to Support Evolving Clinical Needs

MyRisk TestSALT LAKE CITY, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular ...
Medical News Today

CRI Genetics review

Cellular Research Institute (CRI) Genetics is a company that provides ancestry, genetic, and DNA testing. It offers different test packages that may indicate a person’s history, health, or traits.
The Bakersfield Californian

Myriad Genetics to Highlight Genetic Testing Advancements at 2025 National Society of Genetic ...

Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, announced it will share 11 new research ...
The Himalayan Times

Bir Hospital begins simultaneous test for 10 respiratory viruses

Bir Hospital has introduced a new diagnostic facility that can simultaneously test for 10 respiratory viruses, marking a ...
The Caledonian-Record

Myriad Genetics Adds 15 Clinically Actionable Genes to MyRisk® Hereditary Cancer Test to ...

SALT LAKE CITY, Nov. 10, 2025 (GLOBE NEWSWIRE) -- , (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced MyRisk®Hereditary Cancer Test —the gold ...